Detalhe da pesquisa
1.
Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi-site longitudinal survey study.
Cancer
; 130(7): 1101-1111, 2024 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100619
2.
STK11 Adnexal Tumor in an Adolescent Female: Diagnostic Pitfalls of a Recently Described Entity.
Pediatr Dev Pathol
; 26(5): 486-493, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334562
3.
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
Cancer
; 128(15): 2967-2977, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665495
4.
Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors.
Pediatr Blood Cancer
; 68(11): e29282, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34383370
5.
Unrealistic parental expectations for cure in poor-prognosis childhood cancer.
Cancer
; 126(2): 416-424, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31584705
6.
The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor.
Pediatr Blood Cancer
; 67(10): e28559, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32686305
7.
Evaluation of the utility of 99m Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma.
Pediatr Blood Cancer
; 64(11)2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28449267
8.
A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma.
Cancer Immunol Immunother
; 64(10): 1251-60, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26105625
9.
Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors.
Pediatr Blood Cancer
; 61(10): 1792-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24962521
10.
Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621).
Pediatr Blood Cancer
; 61(6): 990-6, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24347462
11.
A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors.
Cancer Med
; 12(12): 13300-13308, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37264747
12.
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor.
J Clin Oncol
; 41(3): 508-516, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206505
13.
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.
Nat Med
; 29(5): 1092-1102, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37012551
14.
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
Neuro Oncol
; 24(10): 1776-1789, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395680
15.
Facial Paralysis From Post-transplant Lymphoproliferative Disorder.
Otol Neurotol
; 42(5): e605-e608, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33443973
16.
Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology.
Cancer Med
; 10(7): 2310-2318, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751835
17.
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.
J Clin Oncol
; 39(31): 3506-3514, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34270348
18.
Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer.
J Pain Symptom Manage
; 60(4): 782-789, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32360991
19.
Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study.
Clin Cancer Res
; 25(20): 6044-6051, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31358541
20.
A Novel ALK Fusion in Pediatric Medullary Thyroid Carcinoma.
Thyroid
; 29(11): 1704-1707, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31650892